Next Article in Journal
Teeth Follow-Up throughout the Life of the Dromedary: Zootechnical and Veterinary Importance
Previous Article in Journal
Cytological and Immunohistochemical Study of the Dromedary Iymph Nodes in Algeria
 
 
Search for Articles:
Title / Keyword
Author / Affiliation / Email
Journal
Article Type
 
 
Advanced Search
 
Section
Special Issue
Volume
Issue
Number
Page
 
Journals
Biology and Life Sciences Forum
Volume 21
Issue 1
10.3390/blsf2023021030
blsf-logo
Submit to this Journal
► Article Menu

Article Menu

share Share announcement Help format_quote Cite question_answer Discuss in SciProfiles thumb_up
...
Endorse textsms
...
Comment
first_page
settings
Order Article Reprints
Font Type:
Arial Georgia Verdana
Font Size:
Aa Aa Aa
Line Spacing:
Column Width:
Background:
Abstract

Regulation of Extrasynaptic Glutamatergic Signaling by Polysialylated NCAM in Health and Disease †

by
Alexander Dityatev
1,2,3
1
Molecular Neuroplasticity Group, German Center for Neurodegenerative Diseases (DZNE), 39120 Magdeburg, Germany
2
Medical Faculty, Otto-von-Guericke-University of Magdeburg, 39120 Magdeburg, Germany
3
Center for Behavioral Brain Sciences (CBBS), 39106 Magdeburg, Germany
†
Presented at Cells, Cells and Nothing but Cells: Discoveries, Challenges and Directions, 6–8 March 2023; Available online: https://cells2023.sciforum.net/.
Biol. Life Sci. Forum 2023, 21(1), 30; https://doi.org/10.3390/blsf2023021030
Published: 3 April 2023
(This article belongs to the Proceedings of Cells, Cells and Nothing but Cells: Discoveries, Challenges and Directions)
Versions Notes

Abstract

:
The neural cell adhesion molecule NCAM is known to mediate cell–to–cell and cell–to–extracellular matrix (ECM) adhesion via homophilic and heterophilic interactions. During brain development, NCAM and the associated glycan, polysialic acid (polySia), play important roles in cell migration proliferation, neurite outgrowth and fasciculation, and synaptogenesis. In the adult rodent brain, NCAM regulates synaptic plasticity, learning, and memory. Dysregulated cortical expression of NCAM and polySia has been reported in Alzheimer’s disease and schizophrenia. Our data demonstrate i) the importance of polySia–NCAM in the balancing of signaling through synaptic/extrasynaptic NMDA receptors and ii) the therapeutic value of short defined-length polySia fragments to restrain GluN2B-mediated signaling in several animal models of neurological and psychiatric diseases.

Funding

This work has been supported by the Italian Institute of Technology and DZNE, the European Union’s Horizon 2020 Research and Innovation Programme under the Marie Sklodowska-Curie grant agreement no. 642881 (ECMED), and DFG SFB 1436 TP A03 (Project-ID 425899996).

Institutional Review Board Statement

All treatments and behavioral procedures were conducted in accordance with animal research ethics standards defined by German law and approved by the Ethical Committee on Animal Health and Care of the State of Saxony-Anhalt (42502-2-1159 DZNE, 42502-2-1343 DZNE, and 42502-2-1346 DZNE) or by the Italian Committee on Animal Health and Care of the governmental body in Rome.

Informed Consent Statement

Not applicable.

Data Availability Statement

Data will be made available on request.

Acknowledgments

I thank Jenny Schneeberg and Katrin Boehm for excellent technical assistance, Inseon Song for helpful discussions of patch-clamp recordings, Rahul Kaushik for helpful discussions of immunohistochemistry, Maura Ferrer for help with spine imaging, Pierre Paoletti for the GluN1 expression vector, and Hristo Varbanov, Shaobo Jia, Gaga Kochlamazashvili, Subhrajit Bhattacharya, Manal Ali Buabeid, Mohamed El Tabbal, Hussam Hayani, Stoyan Stoyanov, Weilun Sun, Oleg Senkov, Hauke Thiesler, Iris Röckle, Herbert Hildebrandt, Eckart Gundelfinger, Vishnu Suppiramaniam, and Rita Gerardy-Schahn for their contributions and support in analysis of polySia functions.

Conflicts of Interest

A.D. filed an international patent application on "Polysialic acid and derivatives thereof, pharmaceutical composition and method of producing polysialic acid”, WO2020025653A2. A.D. is the editor-in-chief in Cell microenvironment section of Cells.
Disclaimer/Publisher’s Note: The statements, opinions and data contained in all publications are solely those of the individual author(s) and contributor(s) and not of MDPI and/or the editor(s). MDPI and/or the editor(s) disclaim responsibility for any injury to people or property resulting from any ideas, methods, instructions or products referred to in the content.

Share and Cite

MDPI and ACS Style

Dityatev, A. Regulation of Extrasynaptic Glutamatergic Signaling by Polysialylated NCAM in Health and Disease. Biol. Life Sci. Forum 2023, 21, 30. https://doi.org/10.3390/blsf2023021030

AMA Style

Dityatev A. Regulation of Extrasynaptic Glutamatergic Signaling by Polysialylated NCAM in Health and Disease. Biology and Life Sciences Forum. 2023; 21(1):30. https://doi.org/10.3390/blsf2023021030

Chicago/Turabian Style

Dityatev, Alexander. 2023. "Regulation of Extrasynaptic Glutamatergic Signaling by Polysialylated NCAM in Health and Disease" Biology and Life Sciences Forum 21, no. 1: 30. https://doi.org/10.3390/blsf2023021030

APA Style

Dityatev, A. (2023). Regulation of Extrasynaptic Glutamatergic Signaling by Polysialylated NCAM in Health and Disease. Biology and Life Sciences Forum, 21(1), 30. https://doi.org/10.3390/blsf2023021030

Article Metrics

Back to TopTop